Fundraising FoxSilverArc Private — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
ADARx is a clinical-stage biotechnology company developing RNA-targeted therapeutics designed to control the expression of disease-driving genes.
BiotechHealthtechMedical DevicesSan Diego, US
Zhen Li(Co-founder, President & CEO)inRui Zhu(Founding Member & Chief Technology Officer)Rob Ackles(Chief People Officer)inRyan Fisk(Chief Financial Officer & Chief Business Officer)inRobert A. MacLeod(Chief Scientific Officer)inChristopher Claeboe(Senior Vice President of Operations)in
Board seatSheila Gujrathi· per SEC Form D · $200M raise · filed Aug 2023
Co-investorsBain Capital Life SciencesOrbiMedSR One Capital ManagementLilly Asia VenturesT. Rowe PriceAscenta Capital+3 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.